PatternsRadar
Sign in

AAREYDRUGS

NSE

Aarey Drugs & Pharmaceuticals Limited

₹101.57+1.31 (+1.31%)Close, 25 Sept 2026

Key statistics

Open
₹98.50
Day range
98.02 – 102.01
52-week range
50.31 – 103.99
From 52w high
-2.3%
Volume
1.13L
Turnover
₹1.1Cr
Delivery
68.5%

20-day avg 60.1%

Rel volume
0.44×
RSI (14)
65.8
ATR (14)
4.03
SMA 50
87.26
SMA 200
77.84

Performance

1 day
+1.31%
1 week
-0.55%
1 month
+25.78%
3 months
+10.40%
6 months
+62.56%
1 year
+36.85%

Delivery percentage

Latest
68.5%

25 Sept 2026

20-day avg
60.1%
1-year avg
82.0%
Percentile
41th

Against its own sessions

Range
20.7–100.0%

1,270 sessions

Over the last 20 sessions AAREYDRUGS settled 60.1% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 82.0%, so recent sessions are running 22.0 points lower than usual. The latest session ranks higher than 41% of the 1,270 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Fundamentals

Market cap
₹288.0 Cr
P/E (TTM)
58.98
EPS (TTM)
₹1.72
Shares outstanding
2.85Cr

Q1 FY27

Listed
6 Aug 2021

Classification

Macro sector
Healthcare
Sector
Healthcare
Industry
Pharmaceuticals & Biotechnology
Basic industry
Pharmaceuticals

NSE publishes no history for this taxonomy, so it is today’s classification rather than the one that held in the past.

Growthlatest filed quarter Q1 FY27

Revenue YoY
-56.34%
Revenue YoY, last 12 filed quarters
Profit YoY
-25.36%
Profit YoY, last 12 filed quarters
Revenue QoQ
-76.45%
Revenue QoQ, last 12 filed quarters
Profit QoQ
-34.27%
Profit QoQ, last 12 filed quarters
Interest cost YoY
-4.84%

Compound growth

Annualised2y3y4y5y6y7y
Revenue-6.2%+6.0%-5.2%———
Profit-3.1%-1.5%-4.3%———

Trailing-twelve-month figures against the same measure that many years earlier, on one reporting basis throughout. Blank where the filed history is too short or either end of the window was a loss — never a number built from less.

About

ISIN
INE198H01019
Series
EQ
History from
6 Aug 2021
Sessions
1,274

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 25 Sept 2026.